OKYO Pharma (OKYO) Enterprise Value (2021 - 2025)

OKYO Pharma (OKYO) has 5 years of Enterprise Value data on file, last reported at -$4.2 million in Q3 2025.

• Enterprise Value for Q3 2025 came in at -$4.2 million, down 410.42% year-over-year; the trailing twelve-month figure through Sep 2025 was -$4.2 million (down 410.42% YoY), and the FY2025 annual result was -$826848.0, changed 0.0% from the prior year.
• Enterprise Value declined to -$4.2 million in Q3 2025 per OKYO's latest filing, from -$826848.0 in the prior quarter.
• Over five years, Enterprise Value peaked at -$826848.0 in Q1 2024 and troughed at -$6.9 million in Q1 2021.
• A 5-year average of -$3.0 million and a median of -$3.4 million in 2022 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 79.56% in 2024, then plunged 410.42% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$6.9 million in 2021, then surged by 60.8% to -$2.7 million in 2022, then sank by 49.79% to -$4.0 million in 2023, then jumped by 79.56% to -$826848.0 in 2024, then sank by 410.42% to -$4.2 million in 2025.
• Business Quant data shows OKYO's Enterprise Value at -$4.2 million in Q3 2025, -$826848.0 in Q1 2025, and -$826848.0 in Q3 2024.